[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Gabapentin Market Status and Outlook 2018-2025

July 2018 | 192 pages | ID: G8B8B4CD70CEN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies
  • Pfizer
  • GSK
  • Sailike
  • Jiangsu Enhua
  • Jiangsu Hengrui
  • Novartis
  • Actavis
  • Glenmark
Market by Type
  • Tablet
  • Capsule
Market by Application
  • Nerve Pain
  • Restless Legs Syndrome
  • Seizures
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Gabapentin Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Tablet
  3.1.2 Capsule
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Nerve Pain
  4.1.2 Restless Legs Syndrome
  4.1.3 Seizures
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Tablet Production by Region
    6.1.1.2 Capsule Production by Region
  6.1.2 Production by Application
    6.1.2.1 Nerve Pain Production by Region
    6.1.2.2 Restless Legs Syndrome Production by Region
    6.1.2.3 Seizures Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Tablet Demand by Region
    6.2.1.2 Capsule Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Nerve Pain Demand by Region
    6.2.2.2 Restless Legs Syndrome Demand by Region
    6.2.2.3 Seizures Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Pfizer
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 GSK
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Sailike
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Jiangsu Enhua
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Jiangsu Hengrui
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Novartis
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Actavis
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Glenmark
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Gabapentin Industry Dynamics & Regulations List
Table Global Gabapentin Sales Revenue, Cost and Margin, 2015-2018E
Table Global Gabapentin Market Status by Type 2015-2018E, in USD Million
Table Global Gabapentin Market Status by Application 2015-2018E, in USD Million
Table Global Gabapentin Market Status by Application 2015-2018E, in Volume
Table Global Gabapentin Market by Region 2015-2018E, in USD Million
Table Global Gabapentin Market Share by Region in 2018, in USD Million
Table Global Gabapentin Market by Region 2015-2018E, in Volume
Table Global Gabapentin Market Share by Region in 2018, in Volume
Table Tablet Production Value by Region 2015-2018E, in USD Million
Table Tablet Production Volume by Region 2015-2018E, in Volume
Table Capsule Production Value by Region 2015-2018E, in USD Million
Table Capsule Production Volume by Region 2015-2018E, in Volume
Table Nerve Pain Production Value by Region 2015-2018E, in USD Million
Table Nerve Pain Production Volume by Region 2015-2018E, in Volume
Table Restless Legs Syndrome Production Value by Region 2015-2018E, in USD Million
Table Restless Legs Syndrome Production Volume by Region 2015-2018E, in Volume
Table Seizures Production Value by Region 2015-2018E, in USD Million
Table Seizures Production Volume by Region 2015-2018E, in Volume
Table Tablet Market Size by Region 2015-2018E, in USD Million
Table Tablet Market Size by Region 2015-2018E, in Volume
Table Capsule Market Size by Region 2015-2018E, in USD Million
Table Capsule Market Size by Region 2015-2018E, in Volume
Table Nerve Pain Market Size by Region 2015-2018E, in USD Million
Table Nerve Pain Market Size by Region 2015-2018E, in Volume
Table Restless Legs Syndrome Market Size by Region 2015-2018E, in USD Million
Table Restless Legs Syndrome Market Size by Region 2015-2018E, in Volume
Table Seizures Market Size by Region 2015-2018E, in USD Million
Table Seizures Market Size by Region 2015-2018E, in Volume
Table GlobalGabapentin Forecast by Type 2019F-2025F, in USD Million
Table Gabapentin Forecast by Type 2019F-2025F, in Volume
Table Gabapentin Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Gabapentin Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Gabapentin Market Forecast by Region 2019F-2025F, in USD Million
Table Gabapentin Market Forecast by Region 2019F-2025F, in Volume
Table Pfizer Information
Table Gabapentin Sales, Cost, Margin of Pfizer
Table GSK Information
Table Gabapentin Sales, Cost, Margin of GSK
Table Sailike Information
Table Gabapentin Sales, Cost, Margin of Sailike
Table Jiangsu Enhua Information
Table Gabapentin Sales, Cost, Margin of Jiangsu Enhua
Table Jiangsu Hengrui Information
Table Gabapentin Sales, Cost, Margin of Jiangsu Hengrui
Table Novartis Information
Table Gabapentin Sales, Cost, Margin of Novartis
Table Actavis Information
Table Gabapentin Sales, Cost, Margin of Actavis
Table Glenmark Information
Table Gabapentin Sales, Cost, Margin of Glenmark
Table Global Gabapentin Sales Revenue by Company 2015-2017, in USD Million
Table Global Gabapentin Sales Volume by Company 2015-2017, in Volume
Table Global Gabapentin Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Gabapentin Picture
Figure Gabapentin Industry Chain Diagram
Figure Global Gabapentin Sales Revenue 2015-2018E, in USD Million
Figure Global Gabapentin Sales Volume 2015-2018E, in Volume
Figure Global Gabapentin Market Status by Type 2015-2018E, in Volume
Figure North America Gabapentin Market Size and Growth 2015-2018E, in USD Million
Figure North America Gabapentin Market Size and Growth 2015-2018E, in Volume
Figure Europe Gabapentin Market Size and Growth 2015-2018E, in USD Million
Figure Europe Gabapentin Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Gabapentin Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Gabapentin Market Size and Growth 2015-2018E, in Volume
Figure South America Gabapentin Market Size and Growth 2015-2018E, in USD Million
Figure South America Gabapentin Market Size and Growth 2015-2018E, in Volume
Figure Middle East Gabapentin Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Gabapentin Market Size and Growth 2015-2018E, in Volume
Figure Africa Gabapentin Market Size and Growth 2015-2018E, in USD Million
Figure Africa Gabapentin Market Size and Growth 2015-2018E, in Volume
Figure Global Gabapentin Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Gabapentin Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Gabapentin Sales Price Forecast 2019F-2025F
Figure Global Gabapentin Gross Margin Forecast 2019F-2025F
Figure Global Gabapentin Sales Revenue by Company in 2018, in USD Million
Figure Global Gabapentin Price by Company in 2018
Figure Global Gabapentin Gross Margin by Company in 2018


More Publications